Bangkok Dusit Medical Services (BDMS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Mar, 2026Executive summary
Operates a large hospital network in Thailand and overseas, with diversified healthcare and supporting businesses.
Financial statements prepared under Thai Financial Reporting Standards, aligned with IFRS.
No significant impact from new or revised accounting standards adopted in 2025.
Financial highlights
Total revenue for 2025: THB 113,272 million, up from THB 109,413 million in 2024.
Net profit for 2025: THB 15,848 million (EPS: THB 1.00), compared to THB 15,987 million (EPS: THB 1.01) in 2024.
Dividend paid in 2025: THB 11,918 million (THB 0.75/share), up from THB 11,122 million (THB 0.70/share) in 2024.
Cash and cash equivalents at year-end 2025: THB 6,342 million, down from THB 7,373 million in 2024.
Outlook and guidance
Board proposes a final dividend of THB 1/share for 2025, totaling THB 15,892 million, with THB 0.65/share to be paid after interim dividend.
Management expects no significant impact from new accounting standards effective in 2026.
Latest events from Bangkok Dusit Medical Services
- Net profit rose to ฿12.16 billion on higher revenue, international growth, and network expansion.BDMS
Q3 202513 Nov 2025 - Revenue and profit rose 4–6% YoY, driven by international patients and network expansion.BDMS
Q2 202515 Aug 2025 - 9M24 net profit rose 12% to ฿11.65 billion on revenue of ฿81.6 billion, driven by patient growth.BDMS
Q3 202413 Jun 2025 - Net profit rose 14% in H1 2024, driven by hospital growth and international patient revenue.BDMS
Q2 202413 Jun 2025 - Net profit rose over 6% YoY, supported by international and upcountry hospital growth.BDMS
Q1 20256 Jun 2025 - Net profit rose to THB 15.99 billion, driven by robust hospital operations and strong revenue growth.BDMS
Q4 20245 Jun 2025